@drmohammedalo: 🚨 Heart failure used to be a death sentence. Eighty percent of patients died within five years. That is no longer true. But most patients never get the treatment that changed the odds. I am a cardiologist. I have watched this gap between evidence and practice cost lives for years. 🫀 There are four proven drug pillars for heart failure with reduced ejection fraction. An ARNI or ACE inhibitor. A beta blocker. An MRA. And an SGLT2 inhibitor. Each one independently cuts mortality. Combine all four and one year mortality risk drops by 73% compared to no therapy at all. 💓 SGLT2 inhibitors go even further. In EMPEROR-Preserved (empagliflozin), cardiovascular death and hospitalization dropped 21%. That happened even in heart failure with preserved ejection fraction, a form that used to have no treatment options at all. That matters because this is not a niche benefit. This changes outcomes for millions. 🩺 Here is the problem. 6.2 million Americans live with heart failure. Most only get a diuretic and a beta blocker. That is one pillar out of four. ⚠️ The gap between what the evidence shows and what patients actually receive is the real crisis in heart failure care today. ❤️ Bottom line: Heart failure is not a hopeless diagnosis anymore. It is an undertreated one. Full GDMT means four drug classes working together, not one or two. A patient on all four pillars faces a completely different future than a patient on partial therapy. Ask your cardiologist a direct question. Am I on all four pillars of GDMT. That question could change your five year survival. Full breakdown of the evidence here: https://dralo.net/blog/congestive-heart-failure Dr. Alo, America’s Cardiologist #Cardiology #HeartFailure #HeartHealth #CardiovascularHealth #GDMT #SGLT2Inhibitors #ARNI #BetaBlockers #PreventiveCardiology #HeartDisease
